Iniparib | m-entrepreneurship.com

Product Name :
Iniparib

Search keywords :
Iniparib

drugId :
null

Target Vo:
Poly (ADP-Ribose) polymerase 1

Target Vo Short Name :
PARP1

Moa_Name:
Poly (ADP-Ribose) polymerase 1 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Sanofi

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Carcinoma, Non-Small-Cell Lung

Termination Status :
Phase 3 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Naratuximab Epigenetics
Trastuzumab emtansine Data Sheet
Toll-Like Receptor 3 Antibody (YA659): Toll-Like Receptor 3 Antibody (YA659) is a non-conjugated and Mouse origined monoclonal antibody about 104 kDa, targeting to Toll-Like Receptor 3 (2F10). It can be used for WB assays with tag free, in the background of Transfected.

Author: Betaine hydrochloride

Related Posts